Randomized Trialhigh evidence
Efficacy of dual antiplatelet therapy for three months versus 12 months after coronary artery bypass grafting: multicentre, double blinded, randomised controlled trial.
BMJ (Clinical research ed.)·May 12, 2026·PMID 42120081
Why it mattersCurrent guidelines recommend DAPT after CABG, but optimal duration is unclear. This large trial provides robust evidence that a shorter 3-month course maintains graft patency while substantially lowering bleeding risk, directly informing post-CABG antiplatelet management.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled